It would be interesting to speculate on the role of SGSH heterozygosity as a potential risk factor for neurodegeneration, as is the case for mutations in other genes involved in lysosome storage disorder, such as those in glucosaminidase (GBA) and Parkinson’s disease. This evidence concerns the gene GBA1 and lysosomal storage disease.